Sui Adds Login with Google and Twitch, Removes Major Barrier to Web3 Adoption
Sui’s “zkLogin” enables Sui dApp developers to offer social authentication, easing onboarding of non-crypto-native users…
Sui’s “zkLogin” enables Sui dApp developers to offer social authentication, easing onboarding of non-crypto-native users…
NEW YORK–(BUSINESS WIRE)–Hill+Knowlton Strategies, one of the world’s leading strategic communications companies, today announced the…
Onfido continues its momentum, being included in 25 G2 reports and receiving seven leader badges…
Multiple novel mRNA biomarkers identified for potential integration into pivotal FDA PMA clinical trial (ReconAAsense)…
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy…
The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022….
Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with…
Christi, Texas–(Newsfile Corp. – September 13, 2023) – Aiming to address a steep rise in…
TOKYO, Sep 13, 2023 – (JCN Newswire) – Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI…
BEIJING, Sep 13, 2023 – (ACN Newswire) – China Energy Summit & Exhibition announces state-owned…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a…
MONTREAL, Sept. 13, 2023 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced the closing of the…
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage…
What you need to know: New Verizon customers and existing customers adding a new line…
Culver City, California–(Newsfile Corp. – September 12, 2023) – Shakti Therapy & Healing Services (424-336-0984),…
Marbella, Panama–(Newsfile Corp. – September 12, 2023) – Knowledge Nuggets Inc. is pleased to announce…
TOKYO, Sep 13, 2023 – (JCN Newswire) – Fujitsu today announced that it has succeeded…
HONG KONG, Sep 13, 2023 – (ACN Newswire) – Wuhan YZY Biopharma Co., Ltd. (“YZY…
Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment…
SEOUL, S.KOREA, Sep 13, 2023 – (ACN Newswire) – HFR, Inc. (KOSDAQ 230240), a leading…